The Lancet is the world's leading general medical journal and specialty journals in Oncology, Neurology and Infectious Diseases. Available online first. Free registration..

words q 1 (max 200)	words q 2 (max 200)	words q 3 (max 200)
Lancet : 4.89 % text : 3.51 % PDF : 3.51 % Full : 3.51 % Online : 1.29 % First : 1.29 % Listen : 1.2 % Oncology : 1.11 % Audio : 1.02 % trial : 0.92 % online : 0.92 % View : 0.92 % health : 0.92 % All : 0.83 % Neurology : 0.83 % Article : 0.83 % randomised : 0.74 % Limits : 0.74 % Issue : 0.74 % Articles : 0.74 % Archive : 0.74 % disease : 0.65 % Diseases : 0.65 % Cited : 0.65 % Infectious : 0.65 % risk : 0.55 % About : 0.55 % has : 0.55 % Most : 0.55 % presentation : 0.55 % times : 0.46 % Research : 0.46 % events : 0.46 % Review : 0.46 % patients : 0.46 % Subscribe : 0.46 % Alerts : 0.46 % AIDS : 0.46 % Issues : 0.46 % mins : 0.37 % May : 0.37 % Writing : 0.37 % Past : 0.37 % HIV : 0.37 % journals : 0.37 % New : 0.37 % RSS : 0.37 % Podcasts : 0.37 % Current : 0.37 % cancer : 0.37 % acute : 0.28 % Conferences : 0.28 % had : 0.28 % whether : 0.28 % obesity : 0.28 % Speaker : 0.28 % than : 0.28 % Contact : 0.28 % treatment : 0.28 % Free : 0.28 % therapy : 0.28 % drug : 0.28 % highlights : 0.28 % increased : 0.28 % heart : 0.28 % screening : 0.28 % diabetes : 0.28 % will : 0.28 % South : 0.28 % type : 0.28 % care : 0.28 % analysis : 0.28 % Privacy : 0.18 % Policy : 0.18 % medicine : 0.18 % Terms : 0.18 % placebo-controlled : 0.18 % compared : 0.18 % since : 0.18 % such : 0.18 % Seroquel : 0.18 % Professor : 0.18 % lowering : 0.18 % AstraZeneca : 0.18 % all : 0.18 % myeloid : 0.18 % more : 0.18 % resuscitation : 0.18 % Video : 0.18 % after : 0.18 % been : 0.18 % prevention : 0.18 % NPSA : 0.18 % letter : 0.18 % who : 0.18 % newborn : 0.18 % which : 0.18 % full : 0.18 % plus : 0.18 % ribavirin : 0.18 % Africa : 0.18 % aspirin : 0.18 % any : 0.18 % other : 0.18 % people : 0.18 % children : 0.18 % year : 0.18 % million : 0.18 % campaign : 0.18 % government : 0.18 % seeking : 0.18 % challenges : 0.18 % Conditions : 0.18 % Morris : 0.18 % Jerry : 0.18 % cardiovascular : 0.18 % Read : 0.18 % Week : 0.18 % Medicine : 0.18 % Password : 0.18 % effects : 0.18 % global : 0.18 % Biotech : 0.18 % Parkinson’s : 0.18 % funding : 0.18 % colorectal : 0.18 % gap : 0.18 % countries : 0.18 % systematic : 0.18 % control : 0.18 % genetic : 0.18 % triglycerides : 0.18 % concentrations : 0.18 % versus : 0.18 % coronary : 0.18 % information : 0.18 % reports : 0.18 % Protocol : 0.18 % evidence : 0.18 % Comment : 0.18 % article : 0.18 % individuals : 0.18 % press : 0.18 % abuse : 0.18 % remembered : 0.18 % Compulsory : 0.18 % licensing : 0.18 % its : 0.18 % Seminar : 0.18 % More : 0.18 % Elsevier : 0.18 % childhood : 0.18 % Migrant : 0.18 % Asthma : 0.18 % new : 0.18 % device : 0.18 % symptoms : 0.18 % complications : 0.09 % metformin : 0.09 % conventional : 0.09 % Intensive : 0.09 % Peginterferon : 0.09 % alfa : 0.09 % week : 0.09 % HOT : 0.09 % cited : 0.09 % parallel-group : 0.09 % UKPDS : 0.09 % blood-glucose : 0.09 % ischaemic : 0.09 % initial : 0.09 % adequate : 0.09 % hepatitis : 0.09 % blinded : 0.09 % have : 0.09 % clopidogrel : 0.09 % sulphonylureas : 0.09 % glycaemic : 0.09 % controlled : 0.09 % chronic : 0.09 % insulin : 0.09 % high-risk : 0.09 % interferonalfa : 0.09 % Age : 0.09 % results : 0.09 % BHF : 0.09 % Once-only : 0.09 % cost-effectiveness : 0.09 % detect : 0.09 % Heart : 0.09 % flexible : 0.09 % Study : 0.09 % cholesterol : 0.09 % Protection : 0.09 % Principal : 0.09 % sigmoidoscopy : 0.09 % Hypertension : 0.09 % low-dose : 0.09 % frequency : 0.09 %	Full text : 3.36 % text PDF : 3.36 % PDF Full : 1.5 % Online First : 1.24 % Lancet Oncology : 0.88 % online Full : 0.8 % All Lancet : 0.71 % Audio Archive : 0.71 % Lancet Neurology : 0.71 % Listen Audio : 0.71 % First Articles : 0.71 % Infectious Diseases : 0.62 % Article Lancet : 0.62 % Lancet pp : 0.53 % pp Full : 0.53 % View presentation : 0.53 % Lancet Infectious : 0.53 % Archive Listen : 0.53 % Articles All : 0.53 % Research Lancet : 0.44 % Review Lancet : 0.44 % Cited times : 0.44 % PDF Cited : 0.44 % Oncology online : 0.35 % mp mins : 0.35 % mins Mb : 0.35 % Mb Listen : 0.35 % Listen Lancet : 0.35 % Past Issues : 0.35 % First Past : 0.35 % Issue Online : 0.35 % Issues Podcasts : 0.35 % New Issue : 0.35 % Subscribe RSS : 0.35 % Alerts Subscribe : 0.35 % Issue Alerts : 0.35 % Current Issue : 0.35 % Podcasts New : 0.35 % About Lancet : 0.35 % Writing Lancet : 0.35 % presentation View : 0.35 % randomised trial : 0.27 % type diabetes : 0.27 % health care : 0.27 % HIV AIDS : 0.27 % Limits events : 0.27 % Contact Us : 0.27 % heart disease : 0.27 % trial Article : 0.27 % Lancet journals : 0.27 % Lancet online : 0.27 % RSS Current : 0.27 % trial Research : 0.27 % licensing Asthma : 0.18 % Biotech global : 0.18 % Migrant abuse : 0.18 % abuse Biotech : 0.18 % Compulsory licensing : 0.18 % Asthma device : 0.18 % device Migrant : 0.18 % Oncology Online : 0.18 % Lancet Online : 0.18 % PDF All : 0.18 % acute myeloid : 0.18 % global health : 0.18 % Diseases Online : 0.18 % NPSA has : 0.18 % Neurology Online : 0.18 % Neurology online : 0.18 % South Africa : 0.18 % colorectal cancer : 0.18 % letter Video : 0.18 % Video Audio : 0.18 % Audio Limits : 0.18 % full letter : 0.18 % View full : 0.18 % b plus : 0.18 % plus ribavirin : 0.18 % Limits Listen : 0.18 % Speaker Professor : 0.18 % Terms Conditions : 0.18 % Conditions Contact : 0.18 % Policy Terms : 0.18 % Privacy Policy : 0.18 % View all : 0.18 % all Limits : 0.18 % aspirin patients : 0.18 % placebo-controlled trial : 0.18 % Read Most : 0.18 % Most Cited : 0.18 % systematic analysis : 0.18 % Most Read : 0.18 % Jerry Morris : 0.18 % AIDS funding : 0.18 % funding gap : 0.18 % Lancet article : 0.18 % article press : 0.18 % pg Full : 0.18 % randomised placebo-controlled : 0.18 % Lancet pg : 0.18 % patients type : 0.18 % press Full : 0.18 % analysis Article : 0.18 % health AIDS : 0.18 % Morris remembered : 0.18 % Parkinson’s disease : 0.18 % Week Medicine : 0.18 % study nor : 0.09 % nor will : 0.09 % will ever : 0.09 % trial has : 0.09 % such study : 0.09 % never been : 0.09 % been such : 0.09 % ever be : 0.09 % has never : 0.09 % be one : 0.09 % Article reports : 0.09 % drug trial : 0.09 % Listen summaries : 0.09 % summaries Lancet : 0.09 % reports how : 0.09 % how individuals : 0.09 % one View : 0.09 % genetically programmed : 0.09 % individuals genetically : 0.09 % involve randomised : 0.09 % would involve : 0.09 % risk ischaemic : 0.09 % ischaemic events : 0.09 % events CAPRIE : 0.09 % CAPRIE Research : 0.09 % patients risk : 0.09 % versus aspirin : 0.09 % blinded trial : 0.09 % trial clopidogrel : 0.09 % clopidogrel versus : 0.09 % times Letter : 0.09 % Letter Editor : 0.09 % method emergency : 0.09 % emergency contraception : 0.09 % contraception would : 0.09 % any method : 0.09 % efficacy any : 0.09 % Editor Fundamental : 0.09 % Fundamental proof : 0.09 % proof efficacy : 0.09 % journals mp : 0.09 % format Listen : 0.09 % Chagas disease : 0.09 % disease mp : 0.09 % Oncology May : 0.09 % May role : 0.09 % associated Chagas : 0.09 % stroke associated : 0.09 % Lithium therapy : 0.09 % therapy ALS : 0.09 % ALS stroke : 0.09 % role zoledronic : 0.09 % zoledronic acid : 0.09 % other issue : 0.09 % issue highlights : 0.09 % highlights discussed : 0.09 % discussed mp : 0.09 % cancer other : 0.09 % breast cancer : 0.09 % acid chemotherapy : 0.09 % chemotherapy early : 0.09 % early breast : 0.09 % May Lithium : 0.09 % Neurology May : 0.09 % screening colorectal : 0.09 % cancer mp : 0.09 % mimic aspects : 0.09 % information mimic : 0.09 % Sigmoidoscopy screening : 0.09 % May Sigmoidoscopy : 0.09 % randomised blinded : 0.09 % aspects drug : 0.09 % Lancet May : 0.09 % genetic information : 0.09 % Using genetic : 0.09 % Hayward highlights : 0.09 % highlights ECCMID : 0.09 % ECCMID mp : 0.09 % Peter Hayward : 0.09 % May Peter : 0.09 % disease Using : 0.09 % cause heart : 0.09 % Diseases May : 0.09 % mp format : 0.09 % C randomised : 0.09 % control sulphonylureas : 0.09 % sulphonylureas or : 0.09 % or insulin : 0.09 % insulin compared : 0.09 % blood-glucose control : 0.09 % Intensive blood-glucose : 0.09 % cited Lancet : 0.09 %	Full text PDF : 3.36 % PDF Full text : 1.5 % text PDF Full : 1.5 % online Full text : 0.8 % Listen Audio Archive : 0.71 % Online First Articles : 0.71 % Audio Archive Listen : 0.53 % pp Full text : 0.53 % Lancet Infectious Diseases : 0.53 % Articles All Lancet : 0.53 % First Articles All : 0.53 % Lancet pp Full : 0.53 % Research Lancet pp : 0.44 % PDF Cited times : 0.44 % text PDF Cited : 0.44 % Podcasts New Issue : 0.35 % New Issue Alerts : 0.35 % Alerts Subscribe RSS : 0.35 % mins Mb Listen : 0.35 % Current Issue Online : 0.35 % Issue Online First : 0.35 % Mb Listen Audio : 0.35 % Online First Past : 0.35 % First Past Issues : 0.35 % mp mins Mb : 0.35 % Issues Podcasts New : 0.35 % Issue Alerts Subscribe : 0.35 % Oncology online Full : 0.35 % View presentation View : 0.35 % Lancet Oncology online : 0.35 % Review Lancet Oncology : 0.35 % Archive Listen Lancet : 0.27 % Archive Listen Audio : 0.27 % Lancet online Full : 0.27 % RSS Current Issue : 0.27 % Past Issues Podcasts : 0.27 % Subscribe RSS Current : 0.27 % trial Research Lancet : 0.27 % Diseases Online First : 0.18 % All Lancet Neurology : 0.18 % Conditions Contact Us : 0.18 % Lancet Neurology Online : 0.18 % Infectious Diseases Online : 0.18 % Lancet Oncology Online : 0.18 % licensing Asthma device : 0.18 % Asthma device Migrant : 0.18 % device Migrant abuse : 0.18 % Compulsory licensing Asthma : 0.18 % full letter Video : 0.18 % All Lancet Oncology : 0.18 % All Lancet Infectious : 0.18 % Oncology Online First : 0.18 % Neurology Online First : 0.18 % Policy Terms Conditions : 0.18 % Neurology online Full : 0.18 % All Lancet Online : 0.18 % Lancet Neurology online : 0.18 % Migrant abuse Biotech : 0.18 % text PDF All : 0.18 % PDF All Lancet : 0.18 % Lancet Online First : 0.18 % randomised trial Research : 0.18 % Privacy Policy Terms : 0.18 % randomised placebo-controlled trial : 0.18 % b plus ribavirin : 0.18 % all Limits events : 0.18 % presentation View all : 0.18 % View all Limits : 0.18 % Terms Conditions Contact : 0.18 % View full letter : 0.18 % pg Full text : 0.18 % press Full text : 0.18 % article press Full : 0.18 % analysis Article Lancet : 0.18 % Video Audio Limits : 0.18 % Audio Limits Listen : 0.18 % Read Most Cited : 0.18 % abuse Biotech global : 0.18 % Jerry Morris remembered : 0.18 % Lancet pg Full : 0.18 % Article Lancet pg : 0.18 % Article Lancet article : 0.18 % AIDS funding gap : 0.18 % health AIDS funding : 0.18 % global health AIDS : 0.18 % Biotech global health : 0.18 % letter Video Audio : 0.18 % Lancet article press : 0.18 % presentation View presentation : 0.18 % patients type diabetes : 0.18 % trial Article Lancet : 0.18 % Most Read Most : 0.18 % events CAPRIE Research : 0.09 % ischaemic events CAPRIE : 0.09 % Letter Editor Fundamental : 0.09 % Editor Fundamental proof : 0.09 % Fundamental proof efficacy : 0.09 % risk ischaemic events : 0.09 % times Letter Editor : 0.09 % Cited times Letter : 0.09 % CAPRIE Research Lancet : 0.09 % Infectious Diseases May : 0.09 % randomised blinded trial : 0.09 % blinded trial clopidogrel : 0.09 % Hayward highlights ECCMID : 0.09 % highlights ECCMID mp : 0.09 % ECCMID mp mins : 0.09 % times randomised blinded : 0.09 % Lancet Neurology May : 0.09 % Listen Lancet Neurology : 0.09 % trial clopidogrel versus : 0.09 % Peter Hayward highlights : 0.09 % clopidogrel versus aspirin : 0.09 % versus aspirin patients : 0.09 % aspirin patients risk : 0.09 % Listen Lancet Infectious : 0.09 % proof efficacy any : 0.09 % May Peter Hayward : 0.09 % Diseases May Peter : 0.09 % patients risk ischaemic : 0.09 % placebo-controlled trial has : 0.09 % Limits Listen summaries : 0.09 % never been such : 0.09 % been such study : 0.09 % Listen summaries Lancet : 0.09 % summaries Lancet journals : 0.09 % journals mp format : 0.09 % Lancet journals mp : 0.09 % such study nor : 0.09 % study nor will : 0.09 % one View full : 0.09 % Cited times randomised : 0.09 % be one View : 0.09 % ever be one : 0.09 % nor will ever : 0.09 % will ever be : 0.09 % mp format Listen : 0.09 % format Listen Lancet : 0.09 % would involve randomised : 0.09 % involve randomised placebo-controlled : 0.09 % trial has never : 0.09 % contraception would involve : 0.09 % emergency contraception would : 0.09 % any method emergency : 0.09 % method emergency contraception : 0.09 % has never been : 0.09 % cancer mp mins : 0.09 % Lancet May Sigmoidoscopy : 0.09 % Listen Lancet May : 0.09 % May Sigmoidoscopy screening : 0.09 % Sigmoidoscopy screening colorectal : 0.09 % colorectal cancer mp : 0.09 % screening colorectal cancer : 0.09 % efficacy any method : 0.09 % lowering low-dose aspirin : 0.09 % colorectal cancer multicentre : 0.09 % prevention colorectal cancer : 0.09 % cancer multicentre randomised : 0.09 % multicentre randomised controlled : 0.09 % randomised controlled trial : 0.09 % screening prevention colorectal : 0.09 % sigmoidoscopy screening prevention : 0.09 % text PDF Once-only : 0.09 % PDF Once-only flexible : 0.09 % Once-only flexible sigmoidoscopy : 0.09 % flexible sigmoidoscopy screening : 0.09 % controlled trial Article : 0.09 % text PDF Most : 0.09 % control sulphonylureas or : 0.09 % blood-glucose control sulphonylureas : 0.09 % sulphonylureas or insulin : 0.09 % or insulin compared : 0.09 % insulin compared conventional : 0.09 % Intensive blood-glucose control : 0.09 % since Intensive blood-glucose : 0.09 % PDF Most cited : 0.09 % Most cited Lancet : 0.09 % cited Lancet since : 0.09 % Lancet since Intensive : 0.09 % cost-effectiveness analysis Article : 0.09 % diabetes cost-effectiveness analysis : 0.09 % adequate glycaemic control : 0.09 % have adequate glycaemic : 0.09 % glycaemic control metformin : 0.09 % control metformin week : 0.09 % metformin week randomised : 0.09 % not have adequate : 0.09 % did not have : 0.09 % sitagliptin patients type : 0.09 % type diabetes who : 0.09 % diabetes who did : 0.09 % who did not : 0.09 % week randomised parallel-group : 0.09 % randomised parallel-group open-label : 0.09 % frequency screening detect : 0.09 % screening detect type : 0.09 % detect type diabetes : 0.09 % type diabetes cost-effectiveness : 0.09 % initiation frequency screening : 0.09 %

Total: 303

the4lancet.com
thbelancet.com
thelancet6.com
thelanct.com
thwelancet.com
tehlancet.com
thyelancet.com
thelanncet.com
thelancwt.com
thelajncet.com
tjelancet.com
thelurncet.com
the.lancet.com
thelaincet.com
wwwthelancet.com
thelazncet.com
1thelancet.com
thelancet7.com
thielancet.com
thelance3t.com
thuelancet.com
theplancet.com
thelanceit.com
thelancdet.com
tehelancet.com
thelwancet.com
htelancet.com
thepancet.com
thelauncet.com
tyhelancet.com
thgelancet.com
thelancetf.com
thelancket.com
thelancetp.com
theancet.com
thelaqncet.com
telancet.com
thulancet.com
thelwncet.com
thelancet2.com
rthelancet.com
thekancet.com
thelancect.com
thelandcet.com
threlancet.com
thelanceft.com
thelsncet.com
rhelancet.com
tshelancet.com
thelancer.com
thelanxet.com
theloncet.com
th4lancet.com
thelzancet.com
9thelancet.com
thelancetz.com
sthelancet.com
thelancrt.com
thaelancet.com
8thelancet.com
gthelancet.com
th3elancet.com
thelanxcet.com
thehlancet.com
dhelancet.com
0thelancet.com
theluncet.com
thelanchet.com
thurlancet.com
qthelancet.com
th3lancet.com
yhelancet.com
thelancetk.com
thelancot.com
thelanceth.com
thelanc3t.com
tgelancet.com
thelajcet.com
thelancet.com
thlancet.com
thelanceti.com
thelahcet.com
thewlancet.com
thelancef.com
therancet.com
thailancet.com
othelancet.com
thelancec.com
thelanceat.com
thelancetq.com
shelancet.com
thelincet.com
thelawncet.com
thelarcet.com
thelantcet.com
thelance6t.com
thwlancet.com
thelanbcet.com
thilancet.com
theklancet.com
thelancte.com
thelsancet.com
hhelancet.com
thelancyet.com
thelanceut.com
thelancest.com
tghelancet.com
thelarncet.com
thelancetl.com
thelancetv.com
thelancoet.com
thelanfet.com
thelancet4.com
tdhelancet.com
dthelancet.com
thealncet.com
thelacet.com
thtelancet.com
thelancst.com
thetlancet.com
thelancet3.com
thslancet.com
6thelancet.com
thelanet.com
thelancetu.com
ttelancet.com
thelkancet.com
tuhelancet.com
tthelancet.com
t6helancet.com
thelancety.com
tyelancet.com
thelyncet.com
ithelancet.com
thelanset.com
theoancet.com
thelabcet.com
fthelancet.com
thelancetc.com
tuelancet.com
zthelancet.com
hthelancet.com
phelancet.com
thelanceg.com
thelancait.com
thelanccet.com
thleancet.com
thelqncet.com
thedlancet.com
thelancetm.com
thelanciet.com
theulancet.com
thelancetr.com
thelanc4et.com
thealancet.com
thnelancet.com
thelanvet.com
chelancet.com
thelanmcet.com
wwthelancet.com
thelencet.com
thelahncet.com
athelancet.com
thelanceta.com
thelance6.com
thelanceh.com
6helancet.com
thelancwet.com
thelancit.com
thelpancet.com
thelanceto.com
thelancetw.com
th4elancet.com
thelances.com
thelancets.com
thelrancet.com
thelanscet.com
thelzncet.com
3thelancet.com
thelancedt.com
thelaancet.com
thelancxet.com
thelancewt.com
the3lancet.com
thelanctet.com
helancet.com
tchelancet.com
theylancet.com
tholancet.com
thelaoncet.com
tnhelancet.com
thselancet.com
kthelancet.com
thelanrcet.com
thelamncet.com
tbhelancet.com
thdelancet.com
thelancyt.com
lthelancet.com
ythelancet.com
thelancetn.com
thelancetb.com
thelanfcet.com
thellancet.com
thelancdt.com
thelance.com
theleancet.com
ghelancet.com
theelancet.com
thoelancet.com
thelatncet.com
thelancret.com
theilancet.com
thrlancet.com
thelancegt.com
thelanjcet.com
theolancet.com
thelancaet.com
jthelancet.com
thelance5t.com
thelnacet.com
thelaencet.com
thelancset.com
thelancat.com
5thelancet.com
thelancete.com
t5helancet.com
5helancet.com
thelanvcet.com
bthelancet.com
thelancetx.com
thelanket.com
thelancetes.com
pthelancet.com
thelayncet.com
thelanceyt.com
xthelancet.com
thelancett.com
tnelancet.com
wthelancet.com
2thelancet.com
tfhelancet.com
cthelancet.com
thel.ancet.com
thelantet.com
theliancet.com
thelyancet.com
thelanceht.com
thelqancet.com
trhelancet.com
thelancert.com
ethelancet.com
thelacnet.com
thelancfet.com
fhelancet.com
thelasncet.com
thelamcet.com
uthelancet.com
thelancet5.com
thelabncet.com
thelanhcet.com
thelancet9.com
thelncet.com
thelansset.com
thelanc3et.com
theloancet.com
thelanceet.com
thelancet1.com
vthelancet.com
thelancetg.com
thelancey.com
thhelancet.com
tjhelancet.com
tbelancet.com
thelantset.com
thelanced.com
thelancut.com
theslancet.com
thalancet.com
the.ancet.com
thylancet.com
mthelancet.com
thelanect.com
thelance5.com
7thelancet.com
thelancetd.com
theluancet.com
4thelancet.com
therlancet.com
thelancurt.com
nthelancet.com
thelance4t.com
thelancetj.com
thelancet8.com
thelancet0.com
thelancuet.com
thjelancet.com
thelankcet.com
thelanc4t.com
thelanceot.com
thelandet.com
thelancvet.com
thdlancet.com